Many people with insulin resistance experience blood sugar swings that cause nausea, shakiness, or cravings
Crockford D, Turjman N, Allan C, Angel J
If you have type 2 diabetes, you may need higher doses or more time to achieve the same degree of appetite suppression as someone without diabetes
A review and analysis of seven tirzepatide trials covering up to 72 weeks of treatment found that tirzepatide produced significant, dose-dependent weight loss, with the clearest results emerging as people moved into higher doses
As an adjunct to meal-time insulin, the injectable amylin analogue pramlintide is approved only in the USA for the treatment of type 1 and type 2 diabetes alike [71]
How Our Doctors Prioritize Safe Semaglutide Treatment Trim Body M.D